Latest Health News

Alara Resources is transitioning its Al Wash-hi project to production, targeting over $100 million in revenue for 2025 amid rising global copper demand. Exploration advances in Oman signal further growth potential.

BTC Health has broadened its medical product portfolio through strategic acquisitions and organic growth, reporting strong early revenue gains while cautiously navigating the uncertain timing of ECMO system adoption.

Aspermont Limited reported a 6% rise in revenue and a 12% increase in EBITDA for the year ended September 2025, yet posted a net loss of A$2.576 million. The company’s financial health shows mixed signals amid ongoing operational improvements.

Delorean Corporation marks a pivotal shift to build-own-operate bioenergy projects with the completion of its $53 million Yarra Valley Water facility and strong progress on its SA1 Salisbury project, backed by $51.5 million in financing and robust market demand.

Singular Health has submitted a 510(k) premarket notification to the FDA for its enhanced 3DICOM MD Cloud platform, aiming to expand imaging capabilities and introduce a scalable, cloud-native solution for medical image management.

BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.

TruScreen Group Limited reported a 17% decline in first half FY2026 product sales but affirmed full-year revenue guidance at NZ$2.8 million, supported by strategic expansions and a successful NZ$4 million capital raise.

Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.

EQ Resources is progressing the refinancing of its €20 million Spanish debt, securing extensions on Oaktree guarantees while negotiating new financing facilities.

Kingsgate Consolidated Limited reported record quarterly gold and silver production at its Chatree Gold Mine, alongside strong cash growth and strategic project advances in its November 2025 AGM update.

Swift Networks reports solid FY25 results with $17.7 million revenue and launches its next-generation Swift TV platform, backed by a recent $1.6 million capital raise and pre-orders across key sectors.

Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.